Entheon Biomedical (XCNQ:ENBI) Common Stock : C$19.96 Mil (As of Nov. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Common Stock?

Entheon Biomedical's quarterly common stock stayed the same from May. 2023 (C$19.35 Mil) to Aug. 2023 (C$19.35 Mil) but then increased from Aug. 2023 (C$19.35 Mil) to Nov. 2023 (C$19.96 Mil).

Entheon Biomedical's annual common stock stayed the same from Nov. 2021 (C$19.35 Mil) to Nov. 2022 (C$19.35 Mil) but then increased from Nov. 2022 (C$19.35 Mil) to Nov. 2023 (C$19.96 Mil).

Entheon Biomedical Common Stock Historical Data

The historical data trend for Entheon Biomedical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Common Stock Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Common Stock

Get a 7-Day Free Trial

2.28

19.35

19.96

Entheon Biomedical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Common Stock	Get a 7-Day Free Trial															19.35	19.35	19.35	19.35	19.96

Entheon Biomedical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines